The MAP2K2 Gene as Potential Diagnostic Marker in Monitoring Adalimumab Therapy of Psoriatic Arthritis

MAP kinases are some of the cascades that are specialized in the cell's response to external stimuli. Their impaired functioning can be observed during the course of psoriatic arthritis. Currently, the best-known class of biological drugs is the inhibitors of the proinflammatory cytokine TNF-α,...

Full description

Saved in:

Bibliographic Details
Published in:	Current pharmaceutical biotechnology Vol. 24; no. 2; p. 330
Main Authors:	Krawczyk, Agata, Strzałka-Mrozik, Barbara, Juszczyk, Karol, Kimsa-Dudek, Magdalena, Wcisło-Dziadecka, Dominika, Gola, Joanna
Format:	Journal Article
Language:	English
Published:	Netherlands 01.01.2023
Subjects:	Adalimumab - pharmacology Adalimumab - therapeutic use Antirheumatic Agents - adverse effects Arthritis, Psoriatic - diagnosis Arthritis, Psoriatic - drug therapy Arthritis, Psoriatic - genetics Cytokines Humans MAP Kinase Kinase 2 Tumor Necrosis Factor-alpha - genetics MAPK2 psoriatic arthritis MAPK adalimumab gene expression anti-TNF
ISSN:	1873-4316, 1873-4316
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!